Your browser doesn't support javascript.
loading
Malignant lymphoma of the oral cavity and the maxillofacial region: Overall survival prognostic factors
Guevara-Canales, Janet-Ofelia; Morales-Vadillo, Rafael; Sacsaquispe-Contreras, Sonia-Julia; Barrionuevo-Cornejo, Carlos; Montes-Gil, Jaime; Cava-Vergiú, Carlos-Enrique; Soares, Fernando-Augusto; Chaves-Netto, Henrique-Duque-de-Miranda; Chaves, Maria-das-Graças-Afonso-Miranda.
Afiliación
  • Guevara-Canales, Janet-Ofelia; USMP. University de San Martín de Porres. Faculty of Dentistry. Lima. Peru
  • Morales-Vadillo, Rafael; USMP. University de San Martín de Porres. Faculty of Dentistry. Lima. Peru
  • Sacsaquispe-Contreras, Sonia-Julia; Peruvian University Cayetano Heredia. Faculty of Dentistry. Lima. Peru
  • Barrionuevo-Cornejo, Carlos; National Institute for Neoplastic Diseases. Specialty in Pathology. Lima. Peru
  • Montes-Gil, Jaime; National Institute for Neoplastic Diseases. Specialty in Pathology. Lima. Peru
  • Cava-Vergiú, Carlos-Enrique; USMP. Dentistry of the University de San Martín de Porres. Lima. Peru
  • Soares, Fernando-Augusto; Hospital A.C. Camargo. Specialty in Pathology. Sao Paulo. Brazil
  • Chaves-Netto, Henrique-Duque-de-Miranda; Federal University of Juiz de Fora. Faculty of Dentistry. s. c. Brazil
  • Chaves, Maria-das-Graças-Afonso-Miranda; Federal University of Juiz de Fora. Faculty of Dentistry. s. c. Brazil
Med. oral patol. oral cir. bucal (Internet) ; 18(4): 619-626, jul. 2013. ilus, tab
Article en En | IBECS | ID: ibc-114483
Biblioteca responsable: ES1.1
Ubicación: BNCS
ABSTRACT
Objective: To identify the overall survival and prognostic factors of malignant lymphoma of the oral cavity and the maxillofacial region. Study Design: Clinical records data were obtained in order to determine overall survival at 2 and 5 years, the individual survival percentage of each possible prognostic factor with the actuarial technique, and the survival regarding the possible prognostic factors with the actuarial technique and the Log-rank and Cox's regression tests. Results: Of 151 subjects, an overall survival was 60% at 2 years, and 45% at 5 years. The multivariate analysis demonstrated statistically significant differences for clinical stage (p=0.002), extranodal involvement (p=0.030), presence of human immunodeficiency virus (p=0.032), and presence of Epstein-Barr virus (p=0.010). Conclusion: The advanced clinical stage and the larger number of involved extranodular sites are related to a lower overall survival, as well as, the presence of previous infections such as the human immunodeficiency and the Epstein-Barr virus (AU)
Asunto(s)
Buscar en Google
Añadir a Mi BVS
Imprimir
XML
Colección: 06-national / ES Base de datos: IBECS Asunto principal: Neoplasias de la Boca / Neoplasias Maxilares / Linfoma Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Med. oral patol. oral cir. bucal (Internet) Año: 2013 Tipo del documento: Article
Buscar en Google
Añadir a Mi BVS
Imprimir
XML
Colección: 06-national / ES Base de datos: IBECS Asunto principal: Neoplasias de la Boca / Neoplasias Maxilares / Linfoma Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Med. oral patol. oral cir. bucal (Internet) Año: 2013 Tipo del documento: Article